Erleada (apalutamide) is a prescription pill used to treat certain types of prostate cancer in adults. It’s usually taken along with other hormone treatments or after you’ve had surgery to remove the testicles. You take it once a day by mouth, with or without food. Erleada (apalutamide) works by blocking testosterone, which helps slow the growth of prostate cancer. Common side effects include tiredness, joint pain, and rash.
Erleada (apalutamide) is an androgen receptor inhibitor. It works by blocking testosterone in prostate cancer cells. Since testosterone helps prostate cancer grow, this medication reduces its effects to slow or stop the cancer from growing or spreading.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Metastatic prostate cancer:
Non-metastatic prostate cancer:
Metastatic prostate cancer:
Non-metastatic prostate cancer:
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
No, Erleada (apalutamide) doesn’t cure cancer. Instead, it helps control prostate cancer by blocking testosterone, which the cancer needs to grow. This can slow down the cancer and keep it from spreading, but the medication doesn’t completely get rid of it.
No, Erleada (apalutamide) isn’t chemotherapy. Chemotherapy works by directly killing fast-growing cells, including cancer cells. Erleada (apalutamide) is a type of hormone therapy called an androgen receptor inhibitor, which blocks testosterone from helping prostate cancer grow and spread.
You usually take Erleada (apalutamide) every day for as long as it keeps your prostate cancer under control. In studies, some people took the medication for several years. There isn’t a set time limit, since treatment depends on how well it works for you and whether side effects become too hard to manage. Your oncologist will check your progress regularly and decide if you should keep taking it.
Hair loss isn’t a common side effect of Erleada (apalutamide). If you do notice changes in your hair while taking this medication, let your oncologist know.
It usually takes about 2 weeks for most of Erleada (apalutamide) to leave your body after a single dose. This time frame is based on the medication's half-life. The half-life is how long it takes for half the medication to leave your body. If you have more questions about how long Erleada (apalutamide) stays in your system, ask your oncologist.
Erleada (apalutamide) can start to work within the first few months of treatment. For some people, it might take a little longer. Your oncologist will check your blood tests and scans over time to see how well it’s working for you.
Erleada (apalutamide) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Serious heart and brain problems, such as heart attack or stroke, have happened in people taking Erleada (apalutamide). Your risk is higher if you have high blood pressure, diabetes, or high cholesterol.
Call your care team or get emergency help right away if you notice warning signs such as sudden chest pain, shortness of breath, dizziness, weakness on one side of the body, trouble speaking, or vision changes.
Erleada (apalutamide) can raise your risk for falls and broken bones, especially if you’re an older adult. These problems can happen months or even years after starting the medication. Tell your oncologist if you develop bone pain or experience falls while taking this medication.
Though rare, Erleada (apalutamide) might put you at risk for seizures. In studies, seizures happened several months to years after starting treatment. Let your oncologist know if you have a history of seizures or are medications that raise the risk for seizures. You should know the risk of seizures and avoid activities where losing consciousness could put you or others in danger, such as driving or swimming alone.
Stop taking Erleada (apalutamide) and tell your oncologist right away if you think you've had a seizure while on treatment because most likely you’ll need to switch to a different medication to treat your prostate cancer. Some early symptoms of a seizure can include having a strange sense of taste or smell, anxiety, nausea, or a fluttering sensation.
Serious and sometimes life-threatening skin reactions have happened in people taking Erleada (apalutamide). These include conditions such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug reaction with eosinophilia and systemic symptoms (DRESS). If one of these reactions is confirmed or is very serious, you’ll need to stop taking the medication for good.
Call your care team right away if you notice warning signs such as fever, flu-like symptoms, mouth sores, swollen lymph nodes, or a spreading skin rash.
Rare but serious lung problems, called interstitial lung disease (ILD) or lung inflammation, have happened in people taking Erleada (apalutamide). Call your care team right away if you notice new or worsening symptoms such as shortness of breath, cough, or fever.
It’s possible for Erleada (apalutamide) to harm an unborn baby. If your partner can get pregnant, use birth control such as condoms while taking this medication and for 3 months after your last dose. Let your oncologist know right away if your partner becomes pregnant during this time.
The typical dose is 240 mg taken by mouth once a day.
Your dose might be different if you experience side effects to this medication.